# Violet Defense

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/violet-defense

- Industry: Biotechnology
- Headquarters: Orlando, US
- Website: www.violetdefense.com
- Total disclosed funding: $20M
- Latest round: Series B (Nov 2, 2021)
- Investors on record: 2

## About

Violet Defense, LLC specializes in advanced ultraviolet (UV) light disinfection technologies, offering innovative solutions that target various environments to combat harmful pathogens and enhance safety.Founded in 2012 and headquartered in Orlando, US, Violet Defense, LLC focuses on UV disinfection solutions, successfully completing 5 deals with the most recent funding round being a Series B in November 2021, where it raised USD 20.00 mn from Katalyst Securities and Kirenaga Partners. The company was established by Mark Nathan, who has a history of founding other ventures. The firm has not undergone any significant pivots in its business strategy since its inception.Violet Defense, LLC provides a range of UV light disinfection products tailored to address specific challenges in healthcare, education, and commercial sectors. These products were released strategically to meet the growing need for effective disinfection solutions in environments prone to infectious pathogens. The company targets markets in North America and Europe, offering solutions that comply with local health regulations and operational requirements.The revenue model of Violet Defense, LLC is structured around B2B sales, facilitating direct transactions with various clients. Engagement typically occurs through partnerships and direct sales, ensuring a continual exchange of value. Their flagship products in the UV disinfection space are competitively priced to reflect their effectiveness and align with customer needs. This approach solidifies revenue streams and fosters long-term relationships.Following the Series B funding round in November 2021, Violet Defense, LLC plans to invest in new product development and expand its global market reach. The company intends to enhance its existing offerings while exploring opportunities in Asian markets by the end of 2023, ensuring a wider adoption of its disinfection solutions. The recent funding will support these initiatives, strengthening the firm’s position in the growing UV disinfection industry.

## Funding rounds

- Series B, Nov 2, 2021, $20M — Kirenaga Partners, Katalyst Securities
- Series A, Apr 21, 2020 — Kirenaga Partners

## Investors

- Kirenaga Partners (https://capitalatlas.ai/funds/kirenaga-partners) — Series A, Series B
- Katalyst Securities — Series B